Bevacizumab as adjuvant for neovascular glaucoma

Volume: 88, Issue: 1, Pages: 103 - 109
Published: Feb 1, 2010
Abstract
. Purpose:  We aimed to evaluate the longterm effects of intraocular bevacizumab (Avastin®) injections as adjuvant treatment in patients with neovascular glaucoma. Methods:  Twenty eyes of 18 consecutive patients with secondary neovascular glaucoma caused by proliferative diabetic retinopathy (n = 7), ischaemic central retinal vein occlusion (n = 7), ischaemic ophthalmopathy (n = 2) and retinal ischaemia resulting from persistent...
Paper Details
Title
Bevacizumab as adjuvant for neovascular glaucoma
Published Date
Feb 1, 2010
Volume
88
Issue
1
Pages
103 - 109
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.